New research confirms Lutetium-177-PSMA-617 is effective for advanced prostate cancer, even after Radium-223 treatment.

The "Lutetium Oxide (CAS 12032-20-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.This report on ...

What's the story of our Moon's early history? Despite all we know about our closest natural satellite, scientists are still ...

Swiss pharma giant Novartis is taking legal action against the Australian cancer care provider as a dispute over how to fund ...